Pfizer Sees Opportunity In Big Pharma’s Move To Specialty Products
This article was originally published in The Pink Sheet Daily
Executive Summary
CEO McKinnell says the move into specialty markets by competitors enables Pfizer to take advantage of openings in the primary care arena.